✓ First British-made tests to be validated in the laboratory by Public Health England (PHE)
✓20 Million tests ordered by the British Government to be used for national rapid testing programme
✓ Used as part of the Government's rapid testing programme for those without symptoms
✓ CE marked and MHRA registered
✓ Highly accurate
✓ Tested and approved to use by Guys and St. Thomas Hospital NHS trust.
✓ Supplied as a box of 25 individual tests (25 x cassettes, 25 x swabs, 25 x vials of buffer solution)
Please note the test cassette does not have a QR code printed on it.
Demonstration Video
Description
SureScreen’s COVID-19 rapid test identifies antigens present in a swab sample and gives a qualitative yes/no result within 15 minutes. The test is perfect for screening quickly at the patient side for the presence of COVID-19. The test can be used as a companion to the antibody test to increase the window of detection.
Implementing rapid screening for COVID-19 has huge time and cost savings when compared to, or integrated into, laboratory screening, and will help to control the spread of the virus by identifying active infection rapidly and accurately. A swab is used to sample from either just inside the nose and introduced into the test cassette by suspension in a buffer solution. These tests are for Proffesional Haelthcare use only.
Benefits
Fast turnaround time with results within 15 minutes
Facilitates regular and scaled up testing options
Cost effective solution
Screen anywhere
Ideal as a triage and screening tool
Easy to use
Directions of use
A swab is used to sample from the nose and introduced into the test cassette by suspension in a buffer solution.
This is usually a stock item - Please allow 1 to 3 working days delivery
In most cases, items in stock that are ordered before 12 noon are delivered on a next working day service.
If you need this item urgently please use the live chat or call us to enquire about our premium rate delivery service including same-day, timed and weekend deliveries. For more information about delivery, please visit our delivery information page here
Antigen tests detect proteins specific to a virus that appears in infected individuals, which indicates active infection. Rapid antigen testing is beneficial because of their portability, ease-of-use, and rapid time to result.
These tests are designed to detect a live virus in people who are highly infectious, whether they are displaying symptoms or not. Their rapid turnaround time allows for mass testing in workplaces and schools without the need for expensive laboratory equipment and analysis.
What Is An Antigen Lateral Flow Test?
SureScreen Lateral flow antigen tests work by taking a sample from the nose and testing that sample for the presence of antigens, the signature proteins of the virus. They show results visually, in the same way as many pregnancy tests.
How Quickly Does Surescreen Rapid COVID-19 Antigen Test Deliver a Result?
An Antigen lateral flow test kits provide a visual, easy to read result in as little as 15 minutes, which means those who test positive can be instructed to isolate quickly and minimise exposure of COVID-19 in your school, workplace or community.
A positive test should be confirmed by a governament approved CPR test.
Have the SureScreen Test been validated by the UK Government
The SureScreen lateral flow test has been tested by the UK Government against the new variants Click Here
Testing was also carried out by Guy's and St Thomas' NHS Hospital Foundation Trust Click Here
The SureScreen Antigen Test Kit is CE marked and registered with the MHRA
What is the Difference Between an Antibody and an Antigen Test?
An antibody test is a blood test to determine if you’ve already been exposed to COVID-19 and have developed the relevan antibodies.
It works by detecting antibodies to SARS COV-2 infection in your blood or serum.
A lateral flow (LFT) antigen test looks for an active COVID-19 infection such as the SARS-CoV-2 virus. If your antigen test is positive, you should self-isolate at home and follow government guidance.
Does my Surescreen Antigen Testing Kit Contain Everything I Need To Perform The Test?
The Surescreen Rapid Lateral Flow testing kits come supplied with all the necessary tools to carry out the test - no extra equipment is needed. The packs include a workstation to lay out the contents in a way that helps workplaces deliver mass testing with ease, organisation and efficiency.
Clear instructions are supplied on how to perform the test and read the results.
While no specialist equipment or laboratory analysis is required, we recommend that these products are used by healthcare professional or trained and competent people.
Are Specialist Personnel Required to Administer the LFT?
The SureScreen LFD antigen tests are designed to be used by Healthcare professionals or by trained and competent individuals.
How Often Should I Check for Symptoms or Test?
As an employer, you need to decide the appropriate timescale between tests. For example, in some sectors (such as health and social care) where interactions with vulnerable individuals are common, repeat rapid antigen testing may be required more often.
This depends on the safety measures that your organisation needs to put in place. The scale of these will be impacted by the size of your workforce, the risk factors identified in your contingency plan and the effect of any requirement to isolate on your ability to continue running your business.
A positive test on the the Surescreen Rapid Antigen test cassette will require for the individual to self isolate and book a Governament approved PCR Covid test immediately for confirmation.
How Do I Store The Surescreen Antigen Test Kit?
The Surescreen Rapid COVID-19 Antigen Test can be stored at room temperature or refrigerated (2-30°C) - please follow instructions on each pack. The test device is stable through the expiration date printed on the sealed pouch. The test device must remain in the sealed pouch until use.
What is the shelf-life of the Surescreen Lateral Flow Test?
Normally the Surescreen Antigen Test have at least 18 months shelf-life, some batches do extend to 24 months expiry date.
What is the extraction buffer?
The extraction buffer includes components to dissociate viral proteins from their surfaces to be used as a target for the test. The method of the extraction buffer is used to prepare the test sample by dissolving the virus shell, which also deactivates the virus.
Does the test kit include transport media?
The test kit includes an extraction buffer that is used to prepare the specimen for testing purposes. The extraction buffer IS NOT transport media and should not be used to preserve or transport specimens.
Can the test be used with alternative specimen types such as nasal swabs or any specimen contained in viral transport media?
The Surescreen Rapid COVID-19 Antigen Test is for direct nasopharyngeal swab specimen only. The test can only be used with the swab provided in the kit.
Can I collect the specimen and test at a later time?
The specimen should be tested immediately after collection. The specimen can be retained up to 1 hour following collection if immediate testing of specimens is not possible. Dispose of the specimen and recollect if retained for more than 1 hour.
Can I freeze the device for long-term storage?
The device should never be frozen. If refrigerated, allow the test kit components to reach room temperature before use.
How do I safely dispose of a used Surescreen Rapid COVID-19 Antigen Test kit?
According to the government instruction leaflets to Carehomes for safe disposal of lateral flow antigen test kits, these can be bagged and disposed of in the normal household waste. Care Home LFD Self test Guidance
Could vaccination cause a false-positive COVID-19 lateral flow device (LFD) antigen test result?
The Surescreen Antigen LFD test detects a different protein of the virus than the one encoded in the vaccine. There is no possibility of cross reaction.
British manufacturer SureScreen Diagnostics to supply 20 million rapid lateral flow
New contract secured with Derby-based manufacturer for validated lateral flow antigen tests, ensuring supply for UK over coming months.
From:
Department of Health and Social Care
Published:
8 February 2021
New tests will support the government’s drive to deliver rapid testing to those without symptoms to break chains of transmission
New tests can return results in 30 minutes, and are the first British-made lateral flow tests validated for asymptomatic testing
The UK government has secured 20 million British-manufactured rapid coronavirus (COVID-19) tests in a new contract with Derby-based test manufacturer SureScreen Diagnostics. These lateral flow antigen tests produce a result in under 30 minutes and are the first British tests to be validated in the laboratory by Public Health England (PHE).
The SureScreen test will be used as part of the government’s rapid testing programme for those without symptoms, which has seen lateral flow tests deployed across the country to test NHS and care home staff, as well as in targeted settings including schools, universities and to allow key workers to continue their vital work during lockdown.
With up to a third of individuals with COVID-19 not displaying symptoms, broadening asymptomatic testing is essential in finding positive cases who may unknowingly pass on the virus in order to break chains of transmission.
The partnerships being created with companies such as SureScreen also supports the wider resilience of the UK British diagnostics industry. The contract will create 200 additional jobs for Derby residents with roles across the whole production line as well as in the wider UK supply chain.
The tests have already been validated by PHE in the lab and are now in their final stage of validation in clinical trials. The tests have been proven to detect the B117 ‘Kent’ variant of COVID-19, and are already CE marked and MHRA registered. Results for the test at the laboratory validation stage show sensitivity against high viral loads was 97.1% and specificity was 99.9%.
Health and Social Care Secretary Matt Hancock said:
Rapid lateral flow tests strengthen our national response to the virus significantly, helping us to identify the around 1 in 3 people who are asymptomatic and break chains of transmission in our workplaces and communities. It is excellent to be working with a UK firm to deliver millions more of these rapid tests.
I am committed to bolstering onshore UK manufacturing capabilities. The brilliant work done by SureScreen, and the contribution it will make to our rapid testing programme, is another example of the home-grown talent, ingenuity and industry that exists right here in the UK.
It remains absolutely paramount that everyone follows the rules to stop the virus spreading further, and comes forward for rapid testing where it is offered. I thank every single person adapting and working to support and protect the country.
Lord Bethell Minister for Health, said:
From the very beginning of this pandemic we have worked with UK manufacturers to support the resilience of UK diagnostics.
It’s fantastic that UK industry has come together to help us all respond to COVID-19 to help stop the spread of the virus.
I am hugely grateful for the considerable work that has been and will continue to be done by British suppliers, manufacturers and entrepreneurs to support our enormous scale up of testing. SureScreen’s rapid tests will help prevent the spread of infection, while supporting jobs and the UK industry across the country.
David Campbell, Director of SureScreen, said:
We believe our rapid antigen tests can really help in screening people both in the community and in clinical settings. Routine testing is crucial to help business, as well as hospitals and GPs.
We are delighted to be working with DHSC on this project and that our tests have been recognised by the government and its scientists. We look forward to doing all we can to help the UK going forward in 2021.
SureScreen is a member of the UK Rapid Antigen Test Consortium, a growing coalition of industry scientists and manufacturers, who have come together to secure lateral flow tests and manufacturing capability for the UK. A secure supply line for the UK for these tests is vital for ensuring the continuation and expansion of rapid regular testing programmes which, alongside vaccine roll-out, will be key for getting people back to work, education and friends and family.
Professor Chris Molloy, Chair UK Rapid Antigen Test Consortium, said:
The UK lateral flow diagnostics industry has come together with intense purpose and the help of government to generate new UK tests and manufacture them at a scale never considered possible.
Their willingness to leave competition at the door in the national service should be celebrated as yet another example of what the UK can do with shared purpose, innovation and drive. This work lays a strong foundation for how the diagnostics industry as a whole will flourish in the UK to improve our future healthcare.
The kind of large-scale community testing that these tests facilitate is part of the government’s COVID-19 winter plan to identify those who may be infectious with coronavirus earlier in order to break the chains of transmission and keep the virus under control. Alongside the rollout of vaccines, rapid regular testing will be key in time to getting people back to doing the things they love.
Lateral flow antigen tests work by taking a sample from the nose or back of the throat and testing that sample for the presence of antigens, the signature proteins of the virus. They show results visually, in the same way as many pregnancy tests. Antigen testing can tell someone whether they currently have the virus that causes COVID-19, and produce results in under 30 minutes.
We are not a Private Testing Provider, we are a supplier of Government Tested Lateral Flow test kits. If you are looking for a Private Testing Provider for travel please visit the UK Government website https://www.gov.uk/find-travel-test-provider
Surescreen COVID-19 Rapid Antigen Lateral Flow Test (Box of 25 Individual Tests)
British manufacturer SureScreen Diagnostics to supply 20 million rapid lateral flow
New contract secured with Derby-based manufacturer for validated lateral flow antigen tests, ensuring supply for UK over coming months.
From:
Department of Health and Social Care
Published:
8 February 2021
New tests will support the government’s drive to deliver rapid testing to those without symptoms to break chains of transmission
New tests can return results in 30 minutes, and are the first British-made lateral flow tests validated for asymptomatic testing
The UK government has secured 20 million British-manufactured rapid coronavirus (COVID-19) tests in a new contract with Derby-based test manufacturer SureScreen Diagnostics. These lateral flow antigen tests produce a result in under 30 minutes and are the first British tests to be validated in the laboratory by Public Health England (PHE).
The SureScreen test will be used as part of the government’s rapid testing programme for those without symptoms, which has seen lateral flow tests deployed across the country to test NHS and care home staff, as well as in targeted settings including schools, universities and to allow key workers to continue their vital work during lockdown.
With up to a third of individuals with COVID-19 not displaying symptoms, broadening asymptomatic testing is essential in finding positive cases who may unknowingly pass on the virus in order to break chains of transmission.
The partnerships being created with companies such as SureScreen also supports the wider resilience of the UK British diagnostics industry. The contract will create 200 additional jobs for Derby residents with roles across the whole production line as well as in the wider UK supply chain.
The tests have already been validated by PHE in the lab and are now in their final stage of validation in clinical trials. The tests have been proven to detect the B117 ‘Kent’ variant of COVID-19, and are already CE marked and MHRA registered. Results for the test at the laboratory validation stage show sensitivity against high viral loads was 97.1% and specificity was 99.9%.
Health and Social Care Secretary Matt Hancock said:
Rapid lateral flow tests strengthen our national response to the virus significantly, helping us to identify the around 1 in 3 people who are asymptomatic and break chains of transmission in our workplaces and communities. It is excellent to be working with a UK firm to deliver millions more of these rapid tests.
I am committed to bolstering onshore UK manufacturing capabilities. The brilliant work done by SureScreen, and the contribution it will make to our rapid testing programme, is another example of the home-grown talent, ingenuity and industry that exists right here in the UK.
It remains absolutely paramount that everyone follows the rules to stop the virus spreading further, and comes forward for rapid testing where it is offered. I thank every single person adapting and working to support and protect the country.
Lord Bethell Minister for Health, said:
From the very beginning of this pandemic we have worked with UK manufacturers to support the resilience of UK diagnostics.
It’s fantastic that UK industry has come together to help us all respond to COVID-19 to help stop the spread of the virus.
I am hugely grateful for the considerable work that has been and will continue to be done by British suppliers, manufacturers and entrepreneurs to support our enormous scale up of testing. SureScreen’s rapid tests will help prevent the spread of infection, while supporting jobs and the UK industry across the country.
David Campbell, Director of SureScreen, said:
We believe our rapid antigen tests can really help in screening people both in the community and in clinical settings. Routine testing is crucial to help business, as well as hospitals and GPs.
We are delighted to be working with DHSC on this project and that our tests have been recognised by the government and its scientists. We look forward to doing all we can to help the UK going forward in 2021.
SureScreen is a member of the UK Rapid Antigen Test Consortium, a growing coalition of industry scientists and manufacturers, who have come together to secure lateral flow tests and manufacturing capability for the UK. A secure supply line for the UK for these tests is vital for ensuring the continuation and expansion of rapid regular testing programmes which, alongside vaccine roll-out, will be key for getting people back to work, education and friends and family.
Professor Chris Molloy, Chair UK Rapid Antigen Test Consortium, said:
The UK lateral flow diagnostics industry has come together with intense purpose and the help of government to generate new UK tests and manufacture them at a scale never considered possible.
Their willingness to leave competition at the door in the national service should be celebrated as yet another example of what the UK can do with shared purpose, innovation and drive. This work lays a strong foundation for how the diagnostics industry as a whole will flourish in the UK to improve our future healthcare.
The kind of large-scale community testing that these tests facilitate is part of the government’s COVID-19 winter plan to identify those who may be infectious with coronavirus earlier in order to break the chains of transmission and keep the virus under control. Alongside the rollout of vaccines, rapid regular testing will be key in time to getting people back to doing the things they love.
Lateral flow antigen tests work by taking a sample from the nose or back of the throat and testing that sample for the presence of antigens, the signature proteins of the virus. They show results visually, in the same way as many pregnancy tests. Antigen testing can tell someone whether they currently have the virus that causes COVID-19, and produce results in under 30 minutes.
We are not a Private Testing Provider, we are a supplier of Government Tested Lateral Flow test kits. If you are looking for a Private Testing Provider for travel please visit the UK Government website https://www.gov.uk/find-travel-test-provider
